Evidence map›Paper›PMID 31216713›Full record

ArticleCells2019

Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver.

Volker Kinast, Stefan L Leber, Richard J P Brown, Gabrielle Vieyres, Patrick Behrendt, Constanze Eßbach, Pavel Strnad, Florian W R Vondran, Markus Cornberg, Cora Wex and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Volker KinastRuhr University Bochum, Faculty of Medicine, Department for Molecular and Medical Virology, 44801 Bochum, Germany. volker.kinast@rub.de.ORCID 0000-0002-6984-678X
Stefan L LeberDepartment of Pathology, Otto-von-Guericke University of Magdeburg, 39106 Magdeburg, Germany. stefan.leber@medunigraz.at.
Richard J P BrownDivision of Veterinary Medicine, Paul Ehrlich Institute, 63225 Langen, Germany. Richard.Brown@pei.de.ORCID 0000-0002-3292-6671
Gabrielle VieyresInstitute of Experimental Virology, Twincore Centre for Experimental and Clinical Infection Research, a joint venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), 30625 Hannover, Germany. gabrielle.vieyres@twincore.de.ORCID 0000-0001-8511-2164
Patrick BehrendtInstitute of Experimental Virology, Twincore Centre for Experimental and Clinical Infection Research, a joint venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), 30625 Hannover, Germany. patrick.behrendt@twincore.de.
Constanze EßbachDepartment of Pathology, Otto-von-Guericke University of Magdeburg, 39106 Magdeburg, Germany. constanze.essbach@med.ovgu.de.
Pavel StrnadDepartment of Internal Medicine III, University Hospital Aachen, 52074 Aachen, Germany. pstrnad@ukaachen.de.ORCID 0000-0002-7122-6379
Florian W R VondranGerman Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30625 Hannover, Germany. Vondran.Florian@mh-hannover.de.
Markus CornbergDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. Cornberg.Markus@mh-hannover.de.
Cora WexDepartment of General, Visceral, Vascular and Transplantation Surgery, Otto-von-Guericke University of Magdeburg, 39106 Magdeburg, Germany. cora.wex@med.ovgu.de.
Thomas PietschmannInstitute of Experimental Virology, Twincore Centre for Experimental and Clinical Infection Research, a joint venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), 30625 Hannover, Germany. thomas.pietschmann@twincore.de.
Johannes HaybaeckDepartment of Pathology, Otto-von-Guericke University of Magdeburg, 39106 Magdeburg, Germany. johannes.haybaeck@med.ovgu.de.
Daniel TodtRuhr University Bochum, Faculty of Medicine, Department for Molecular and Medical Virology, 44801 Bochum, Germany. daniel.todt@ruhr-uni-bochum.de.ORCID 0000-0002-3564-1014
Eike SteinmannRuhr University Bochum, Faculty of Medicine, Department for Molecular and Medical Virology, 44801 Bochum, Germany. eike.steinmann@ruhr-uni-bochum.de.
Medizinische Hochschule Hannover · DEHelmholtz Centre for Infection Research · DEOtto-von-Guericke-Universität Magdeburg · DERuhr University Bochum · DEGerman Center for Infection Research · DEInnsbruck Medical University · ATMedical University of Graz · ATPaul Ehrlich Institut · DEUniversitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratin proteins form intermediate filaments, which provide structural support for many tissues. Multiple keratin family members are reported to be associated with the progression of liver disease of multiple etiologies. For example, keratin 23 (KRT23) was reported as a stress-inducible protein, whose expression levels correlate with the severity of liver disease. Hepatitis C virus (HCV) is a human pathogen that causes chronic liver diseases including fibrosis, cirrhosis, and hepatocellular carcinoma. However, a link between KRT23 and hepatitis C virus (HCV) infection has not been reported previously. In this study, we investigated KRT23 mRNA levels in datasets from liver biopsies of chronic hepatitis C (CHC) patients and in primary human hepatocytes experimentally infected with HCV, in addition to hepatoma cells. Interestingly, in each of these specimens, we observed an HCV-dependent increase of mRNA levels. Importantly, the KRT23 protein levels in patient plasma decreased upon viral clearance. Ectopic expression of KRT23 enhanced HCV infection; however, CRIPSPR/Cas9-mediated knockout did not show altered replication efficiency. Taken together, our study identifies KRT23 as a novel, virus-induced host-factor for hepatitis C virus.

Indexed as

Carcinoma, HepatocellularCell LineHEK293 CellsHepacivirusHepatitis CHepatitis C, ChronicHepatocytesHost-Derived Cellular FactorsHost-Pathogen InteractionsHumansKeratinsKeratins, Type ILiverLiver CirrhosisLiver NeoplasmsRNA, MessengerHost-Derived Cellular FactorsKeratinsKeratins, Type IKRT23 protein, humanRNA, Messengerhepatitis C virus (HCV)host factorkeratin 23virus–host interaction

Identifiers

PMID31216713
PMCPMC6628310
OpenAlexW2950930184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.